Monday, October 26, 2026

Dollar Hits 2022 Low as Euro Surges 14%, Pound Faces $1.30 Break

The Bloomberg Dollar Spot Index fell to its lowest level since 2022, driving a multi-year currency realignment across major forex pairs. The euro gained 14% against USD in 2025 while the pound advanced 7%, though GBP recently dropped to €1.13—its weakest since April 2023. Analysts forecast further sterling weakness below $1.30 as safe-haven flows shift to the Swiss franc.

Dollar Hits 2022 Low as Euro Surges 14%, Pound Faces $1.30 Break
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The Bloomberg Dollar Spot Index dropped to its lowest level since 2022, accelerating a currency realignment that has reshaped forex markets. The euro surged 14% against the dollar in 2025, while the British pound gained 7% over the same period.

Recent trading sessions reversed some of those gains. GBP/EUR fell to €1.13, the pound's weakest level against the euro since April 2023. The pound traded at $1.3086 after declining 0.5%, extending pressure on sterling across multiple pairs.

Simon Phillips, Managing Director at No1 Currency, noted mounting pressure on the pound as UK gilt yields climbed. UK 30-year gilt yields rose 4 basis points to 5.21%, matching August's highest level since 1998. The yield surge came as an inflation-linked bond auction drew £69 billion in bids for £4.25 billion in debt—a record exceeding March's £67.5 billion.

Jordan Rochester, analyst at Mizuho Bank, forecast the pound could fall below $1.30 in coming sessions. The currency faced dual headwinds from rising borrowing costs and fiscal concerns ahead of Chancellor Rachel Reeves' November 26 Budget.

The dollar's broad weakness reflects shifting monetary policy expectations and capital flows. Safe-haven demand drove strength in the Swiss franc as investors sought alternatives to dollar-denominated assets. The franc's gains came alongside gold prices climbing above $4,100 per ounce.

For forex traders, the realignment creates opportunities across currency pairs. EUR/USD momentum remains strong despite the euro's substantial year-to-date gains. GBP pairs show increased volatility, with short-term traders targeting the $1.30 level on cable (GBP/USD).

The currency moves coincided with record highs in European equities. The Stoxx 600 reached 583.4 points, up 0.6%, while Germany's DAX gained 0.9%. London's FTSE 100 closed at 9,911, just shy of the intraday peak of 9,930.

Neil Wilson, analyst at Saxo Markets, highlighted fiscal instability risks driving currency volatility. The UK's high proportion of inflation-linked bonds—approximately 25% compared to 10% in the US and France—amplifies sensitivity to yield movements.

Currency traders should monitor upcoming UK fiscal announcements and central bank commentary for directional cues. The multi-year nature of this realignment suggests further moves ahead as markets digest changing economic fundamentals across major economies.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com